Morning Headlines 10/19/17

Tom Marino, Drug Czar Nominee, Withdraws in Latest Setback for Trump’s Opioid Fight

A 60 Minutes and Washington Post investigative report exposes a multi-year effort by drug distributor lobbyists to push an industry-friendly bill through Congress that ultimately undercut the DEA’s drug distribution enforcement options at the height of the opioid epidemic. Rep. Tom Marino (R-PA), President Trump’s Drug Czar nominee, withdrew his name from consideration after the report called him the “chief advocate of the law that hobbled the DEA.”

IBM shares up after earnings beat

IBM reports Q3 results: $19.15 billion in revenue and $3.3o adjusted EPS, beating analyst expectations on both, but marking its 22nd straight quarter without revenue growth. The company’s AI business unit brought in $4.4 billion in revenue, up 4 percent.

Virtual Therapists Help Veterans Open Up About PTSD

Wired covers the use of teletherapy in the treatment of PTSD among veterans.

White House says Trump opposes Senate’s bipartisan Obamacare deal

In a reversal, the White House now says it opposes the bipartisan deal drafted by Senators Lamar Alexander (R-TN) and Patrick Murray (D-WA) that would stabilize ACA marketplaces and restore the payment of cost-sharing subsidies.